Home / Products / Pharmacopoeial impurities / Brimonidine Impurity 13

Brimonidine Impurity 13

CAS 134892-42-5 Cat. no. RA-B040001 On synthesis

A pharmacopoeial impurity reference standard for this drug substance, characterised by HPLC, mass spectrometry and 1H NMR, and released with a lot-specific certificate of analysis.

Molecular formulaC11H14BrN5
Molecular weight296.17 g/mol
Available packsOn request
DocumentationCOA · SDS · spec sheet
StorageSee certificate

No price is published: pack size, documents and shipping are confirmed in one quotation.

Chemical structure of Brimonidine Impurity 13, CAS 134892-42-5

What this record covers

Brimonidine Impurity 13 (CAS 134892-42-5) is supplied as a pure organic reference material under ISO 17034:2016 (ANAB, AR-2832). Each lot is weighed, dispensed and released against a specification that includes identity by mass spectrometry and 1H NMR, and purity by HPLC.

Typical use

Related-substance method development and validation, identification of impurity peaks in this drug substance drug substance, system suitability, and quantitative calibration where a defined reference is required.

Shipping and storage

Shipped worldwide with the SDS and, where applicable, a non-hazardous declaration. Cold-chain and dry ice are used when the material requires it; the storage condition and retest date are stated on the lot certificate rather than assumed from the catalogue.

Identifiers: catalogue RA-B040001 · CAS 134892-42-5 · formula C11H14BrN5 · MW 296.17. If you need a different pack size or a co-lot certificate, ask — both are routine.

Other standards for this drug substance